Triage of women with minor cervical lesions: Data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-6

  Sørbye, Sveinung Wergeland ^a   Fismen, Silje ^a   Gutteberg, Tore ^a,b   Mortensen, Elin Synnøve ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN E7; VIRUS RNA; ONCOPROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EMERGENCY HEALTH SERVICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS EXAMINATION; AGED; ALPHAPAPILLOMAVIRUS; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; RNA, VIRAL; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77958554393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012724     Document Type: Article

References (19)

1. The Norwegian cervical cancer screening programme. Annual report 2008]. The Cancer Registry of Norway.
2. Cancer in Norway 2008. Cancer incidence, mortality, survival and prevalence in Norway. The Cancer Registry of Norway.
3. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUSLSIL Triage Study. JAMA 285: 1500-1505.
4. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, et al. (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337: a1284.
5. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, et al. (2006) Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367: 489-498.
6. Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, et al. (2008) Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 17: 3033-3042.
7. Molden T, Kraus I, Karlsen F, Skomedal H, Nygård JF, et al. (2005) Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women.30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 14: 367-372.
8. Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, et al. (2005) Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer 114: 973-976.
9. Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, et al. (2005) DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 97: 908-915.
10. Trope A, Sjøborg K, Eskild A, Cuschieri K, Eriksen T, et al. (2009) Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 47: 2458-2464.
11. Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, et al. (2009) Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 47: 3895-3901.
12. Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, et al. (2010) Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer. J Clin Microbiol 48: 2779-2785.
13. Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES (2010) HPV mRNA test in women with minor cervical lesions: Experience of the University Hospital of North Norway. J Virol Methods. In press.
14. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
15. Arbyn M, Buntinx F, Van RM, Paraskevaidis E, Martin-Hirsch P, et al. (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a metaanalysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96: 280-293.
16. Jeronimo J, Schiffman M (2006) Colposcopy at a crossroads. Am J Obstet Gynecol 195: 349-353.
17. Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, et al. (2006) Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 66: 10112-10119.
18. Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE (2008) Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ 337: a1343.
19. Sjøborg KD, Vistad I, Myhr SS, Svenningsen R, Herzog C, et al. (2007) Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand 86: 423-428.